
Paul Kohlhaas
Core contributor at VitaDAO · Founder at BIO Protocol · Team at ConsenSys · Cofounder, CEO at Molecule
Paul Kohlhaas is an entrepreneur and economist with a passion for open source utility networks. A profound passion for pharmaceutical innovation led him to found Molecule, a networked marketplace that enables the distributed R&D and funding of new chemical intellectual property. His research centers around the use of token engineering and autonomous market design to design novel incentive and legal structures that drive open source collaboration. He previously graduated in economics and politics from the University of St. Gallen, co-founded Linum Labs, a blockchain architecture studio and worked . years at ConsenSys, uPort, pioneering early real-world implementations in digital identity.
Current Roles
News Mentions
Ethereum app builder Consensys has delayed its potential IPO until fall
This AI Reads Your Chemistry Instructions and Finds the Best Way to Build You a Molecule
Shodai Network completed a $2.5 million seed round financing, with participation from Consensys and others
Consensys Taps DeFi Giant Aave for Metamask Stablecoin Yield
Consensys Taps Aave to Launch Stablecoin Yield in MetaMask Wallets
Ethereum’s ‘Trustware’ era could push ETH to $15.8K — Consensys
Consensys CEO Joe Lubin Is Poised to Become Ethereum’s Michael Saylor
Ethereum's new staking limit is not a risk to decentralization, says Consensys researcher
Solana, Consensys and Uniswap donated to Trump's $239 million inauguration fund
Consensys, Solana, and Uniswap CEO donated to Trump's $239M inauguration fund



